Experimental cancer drug trial halted early
Disease control
Terminated
This early-stage study tested a new drug called KD033 in 45 adults with advanced solid tumors that had spread. The main goal was to check safety and find the right dose, not to cure the cancer. The study was stopped early, so results are limited.
Phase: PHASE1 • Sponsor: Kadmon, a Sanofi Company • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC